SCHEMBL2720155

SCHEMBL2720155

CC(C)(C)[Si](C)(C)OCC(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20438667 0.82 DUT (0.40)
SCHEMBL1876097 0.81 BACE1 (0.31)
SCHEMBL1085871 0.81 MAPT (0.33)
SCHEMBL9163997 0.79 BACE1 (0.30)
SCHEMBL2163046 0.79 TSHR (0.40)
SCHEMBL28790081 0.78 MAPT (0.31)
SCHEMBL10702400 0.78 TSHR (0.36)
SCHEMBL6470838 0.78
SCHEMBL22033623 0.77
SCHEMBL8451321 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005082892-A2 TRIAZOLE COMPOUNDS AS ANTIBACTERIAL AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S LABORATORIES LTD. (IN) 2005-09-09 WO claimed
CN-119591621-A Novel ecteinascidin derivatives, preparation method and application thereof, antibody drug conjugate and application thereof 泰诚思(上海)生物医药有限公司 2025-03-11 CN disclosed
EP-3773563-B1 PRODRUGS OF FUSED-BICYCLIC C5AR ANTAGONISTS CHEMOCENTRYX INC (US) 2024-10-16 EP disclosed
CN-111954525-B Prodrugs of fused bicyclic C5aR antagonists 凯莫森特里克斯股份有限公司 2023-12-26 CN disclosed
US-11608336-B2 Prodrugs of fused-bicyclic C5aR antagonists CHEMOCENTRYX, INC. (US) 2023-03-21 US disclosed
CN-111393444-B Preparation method of abacavir hydroxy acetate 上海迪赛诺化学制药有限公司 2022-10-28 CN disclosed
EP-3448853-B1 COMPOUNDS FOR MODULATING AQUAPORINS APOGLYX AB (SE) 2021-11-17 EP disclosed
EP-3448853-B1 COMPOUNDS FOR MODULATING AQUAPORINS APOGLYX AB (SE) 2021-11-17 EP disclosed
US-20210052612-A1 PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS CHEMOCENTRYX, INC. 2021-02-25 US disclosed
CN-111954525-A Prodrugs of fused bicyclic C5aR antagonists 凯莫森特里克斯股份有限公司 2020-11-17 CN disclosed
US-4920148-A C-29 oximinomilbemycin CIBA-GEIGY CORPORATION (US) 1990-04-24 US disclosed
US-4897416-A 5-OXIMINO-13B-CARBONYLTHIOMILBEMYCIN DERIVATIVES CIBA-GEIGY CORPORATION (US) 1990-01-30 US disclosed
US-4871719-A MILBEMYCIN CIBA-GEIGY CORPORATION (US) 1989-10-03 US disclosed
US-4855317-A Insecticides and parasiticides CIBA-GEIGY CORPORATION (US) 1989-08-08 US disclosed
EP-0074758-B1 4A-SUBSTITUTED AVERMECTIN COMPOUNDS, THEIR PRODUCTION AND ANTIPARASITIC USE, AND COMPOSITIONS CONTAINING THEM MERCK & CO. INC. (US) 1986-07-16 EP disclosed
US-4550160-A Processes for the interconversion of C-076 compounds MERCK & CO., INC. (US) 1985-10-29 US disclosed
EP-0040913-B1 23-KETO DERIVATIVES OF C-076 COMPOUNDS, THEIR PREPARATION AND ANTI-PARASITIC USE MERCK & CO. INC. (US) 1984-07-25 EP disclosed
US-4328335-A PARASITICIDES, CULTURE PRODUCT OF STREPTOMYCES REACTED WITH A THIOCARBONYL HALIDE MERCK & CO., INC. (US) 1982-05-04 US disclosed
EP-0040913-A1 23-Keto derivatives of C-076 compounds, their preparation and anti-parasitic use MERCK & CO. INC. (US) 1981-12-02 EP disclosed
US-4289760-A ANTHELMINTICS, PARASITICIDES MERCK & CO., INC. (US) 1981-09-15 US disclosed